A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination with Background Therapy in Adult Participants with Pulmonary Arterial Hypertension (TROPOS Study)

Investigator: Sandeep Sahay, MD

Study Coordinator: Cassidy Smith

Status: Enrolling

ClinicalTrials.gov Number: N/A

Phone: 713.441.4106

Protocol Number: PRO00037676

Description

Study KER-012-A201 is Phase 2, double-blind, randomized, placebo-controlled study to determine the efficacy and safety of KER-012 compared to Placebo in adults with PAH (WHO Group 1 PH) on stable background PAH therapy. The study is divided into the Screening Period, Treatment Period, Extension Period, and Follow-Up Period. The design of this study will control bias in the assignment of study treatment as well as in data interpretation, particularly of the measures that may have clinical variability (e.g., PVR and 6-minute walk distance [6MWD])
More to Explore
Search Clinical Trials
Join a Clinical Trial
Clinical Research Support Services for Investigators
Weill Cornell Medical College Clinical Trials